We present a case of a 9-year-old female child who we are managing for pure non-gestational ovarian choriocarcinoma at Kenyatta National Hospital. It is an extremely rare germ cell tumor and quite aggressive. Subtotal hysterectomy, bilateral salpingo-oophorectomy, partial omentectomy and appendicectomy was done. The child is currently undergoing adjuvant chemotherapy. Prognosis is however reported to be dismal.
Introduction
Ovarian Choriocarcinoma can arise in one of three ways: as a primary choriocarcinoma associated with ovarian pregnancy; as a metastatic choriocarcinoma from a primary gestational choriocarcinoma arising in other parts of the genital tract, mainly the uterus; and as a germ cell tumor differentiating in the direction of trophoblastic structures and admixed with other neoplastic germ cell elements [1] . A tumor arising in the latter way is classified as a non-gestational choriocarcinoma, and when the tumor has only trophoblastic elements, then it is a pure non-gestational choriocarcinoma as in our patient.
Case presentation
We present a case of a 9yr old female child who presented to Kenyatta National hospital with a 3/12 history of abdominal swelling. It was initially in the suprapubic region and gradually increased in size up to the epigastric region. The mass was constantly painful. The child also had nausea and vomiting, mostly in the mornings, loss of appetite and there was history of weight loss. She did not have fevers. She had per vaginal bleeding 2/12 prior to admission. Her pubic hair and breasts also started to form within the 3 months of symptoms (Fig. 1) .
On examination, she was alert though lethargic, pale and wasted. On abdominal exam, there was a palpable mass with a fundal height of 30/40, tender, firm, immobile, with smooth surface and no skin changes. Digital rectal exam revealed an anterior firm mass which was tender and adherent to the rectal mucosa.
Other systemic examination was normal
Laboratory investigations; Full blood count showed decreased haemoglobin levels of 6.8 g/dl and the other parameters were within the normal limits. Serum tumor markers showed an elevated B-HCG levels of 444,900 mIU/ml (0-4), CEA of 1.53 ng/ml (0-5), CA 125 of 48.32U/ ml (0−35) and AFP of 0.70 IU/ml (0-5).
A diagnosis of germ cell tumor was made based on the elevated B-HCG and normal AFP serum levels.
A pelvic ultrasound scan showed a large complex heterogenous pelvic mass with extension to abdomen and with cystic degenerations within it. MRI abdominopelvic ( Fig. 2) showed a complex mass arising from the pelvis with enhancing septations measuring 17 × 14 × 8 cm. The ovaries were not clearly delineated from the mass. A chest x-ray showed clear lung fields.
We transfused the child and an informed consent was given for a laparotomy. Intraoperatively, we found minimal ascites and an abdominopelvic mass. It was arising from the left ovary. It had an omental cover and adherent to the gut at the ascending, transverse, descending and sigmoid colon. The appendix and rectum were also adherent to the tumor. (Fig. 3) . The mass was infiltrating the uterus, fallopian tubes and the right ovary. The liver was grossly free of the tumor.
Adhesiolysis, excision of the mass, sub-total hysterectomy, bilateral salpingo-oophorectomy and appendectomy was done. However, https://doi.org/10.1016/j.epsc.2018.10.005 Received 29 September 2018; Accepted 10 October 2018 remnants of the tumor adherent to the rectum were left and there was peritoneal spillage during excision of the tumor. An implantable subcutaneous venous access port was also inserted for administration of adjuvant chemotherapy (see Figs. 4-7) .
Prominent lymphovascular invasion and necrosis was seen (Fig. 8) .
Histology of the appendix showed tumor infiltrating the serosal surface towards the lumen (Fig. 9) .
Discussion
Choriocarcinoma are the most aggressive form of gestational trophoblastic diseases owing to their rapid growth and metastatic potential. Choriocarcinoma of the ovary can be either gestational or nongestational type. The presence of corpus luteum of pregnancy adjacent to the tumor indicates the gestational type while a search for paternal DNA allows a definite distinction between the two types with gestational having paternal genomic structure while non-gestational having genomes of only maternal origin [2] . DNA polymorphism is however not readily available in our laboratory setup and was thus not done. Goswami et al. however suggested that a diagnosis of non-gestational choriocarcinoma be reserved for pre-menarchial girls [4] . Our patient was 9 years old and may have just began to experience her menses as there was an episode of per vaginal bleeding two months prior to presentation.
Non-gestational ovarian choriocarcinoma (NGCC) is exceedingly rare and accounts for only 0.6% of all ovarian malignancy with a mean age of 13.6 ± 6.9 years old [3, 4] .
NGCC is usually of mixed type associated with other germ cell tumours such as immature teratoma, endodermal sinus tumor, embryonal carcinoma and dysgerminoma [4] . The tumor has a marked tendency to metastasize early by blood-borne dissemination, to the lungs (80%), pelvis (20%), vagina (30%), liver (10%) and other rare sites including gastrointestinal tract, spleen and kidney. The central nervous system is seldom involved in the absence of pulmonary metastases [5] . Brain metastasis have been associated with the worst prognosis as they are often associated with haemorrhage due to the syncytiotrophoblasts propensity to infiltrate vessel walls. Our patient had extensive local metastasis of the tumor which had infiltrated the uterus, both fallopian tubes and the contralateral ovary. There was GIT involvement as the tumor had also infiltrated rectum and appendix. Histological examination of the appendix showed tumor infiltrating the serosa surface towards the lumen and there was prominent lymphovascular invasion by tumor cells. She was classified as stage IIIC as per International Federation of Gynecology and Obstetrics (FIGO) guidelines [6] . There was no evidence at the time of presentation of pulmonary metastasis. However proper follow up during treatment and even beyond is required as non-gestational choriocarcinoma has been shown in a case study to have late metastasis presenting up to two years later to the brain despite appropriate chemotherapy [7] . There is no clear consensus on the right chemotherapy regimen to be used with majority of patients being put on methotrexate based regimens for both gestational Choriocarcinoma and non-gestational choriocarcinoma. On direct assessment by Lin et al., there was no major difference between patients on germ cell tumor regimens (bleomycin, etoposide, cisplatin) versus methotrexate based regimens [8] . Our patient is on a methotrexate based multi agent regimen: etoposide, methotrexate, actinomycin-D, cyclophosphamide and vincristine and we await to see her response to the regimen.
Conclusion
Despite the extremely low incidence of pure non-gestational choriocarcinoma, there is sufficient evidence in literature that cytoreductive surgery in combination with post-operative chemotherapy may be an effective therapeutic strategy for pure ovarian choriocarcinomas. Though non-gestational choriocarcinoma has been shown to have a worse prognosis, there are also numerous cases of complete resolution of symptoms. We envision that as we follow up our patient she will be among the successful cases.
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